Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal DisordersLloyd Paul Aiello, George L. King, Paul G. Arrigg et al.|New England Journal of Medicine|1994Cited by 3.8k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.Lloyd Paul Aiello, Lois E. H. Smith, George L. King et al.|Proceedings of the National Academy of Sciences|1995Cited by 1.3k
Retinopathy in DiabetesDonald S. Fong, Ronald Klein, Jerry D. Cavallerano et al.|Diabetes Care|2004Cited by 1.1k
Vascular Endothelial Growth Factor–Induced Retinal Permeability Is Mediated by Protein Kinase C In Vivo and Suppressed by an Orally Effective β-Isoform–Selective InhibitorLloyd Paul Aiello, George L. King, Elia J. Duh et al.|Diabetes|1997Cited by 669
Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth.Pu Xia, George L. King, Lloyd Paul Aiello et al.|Journal of Clinical Investigation|1996Cited by 570